Skip to main content

Africa gets 'holistic' drug discovery centre

By


Munyaradzi Makoni
14 April 2011
http://www.scidev.net/en/sub-suharan-africa/africa-gets-holistic-drug-discovery-centre.html?utm_source=link&utm_medium=rss&utm_campaign=en_subsuharanafrica

[CAPE TOWN] A "holistic" research centre described as the first of its kind in Sub-Saharan Africa to bridge the gap between basic sciences and drug development was launched in South Africa last week (7 April).

The Drug Discovery and Development Centre, known by the acronym H-3D, will focus on developing and testing preclinical drug candidates for diseases afflicting the continent, and will train African scientists in skills needed for drug discovery, integrating medicinal chemistry, biology and pharmacology.

It will allow "Africans to find their own solutions to their own health problems," said Kelly Chibale, founding director and a chemist at University of Cape Town (UCT), which will host the centre.

The aim is to achieve a "critical mass of personnel" to help make Africa competitive enough to attract contracts from the pharmaceutical industry and research organisations, and create jobs in Africa, Chibale said.

"South Africa has a strong reputation in developing basic sciences and clinical studies, so researchers will bridge the gap that has always existed in translating knowledge into new medicines," Chibale told SciDev.Net. But he added that even South Africa, the most technologically advanced economy in Sub-Saharan Africa, has gaps in knowledge and expertise of the drug discovery chain ­ something the centre will try to fill.

Research will focus on drugs for the treatment of malaria, tuberculosis and cardio-vascular diseases.

Mamphela Ramphele, chairperson of the Technology Innovation Agency (TIA), South Africa, said researchers should seize this opportunity to also tackle diseases such as typhoid, cholera and river blindness, which are largely confined to Africa.

But it will be a long time before drugs could start rolling out, Chibale cautioned: "I don't want to create any unrealistic expectations. We will kiss many frogs before meeting the prince."

Timothy Wells, chief scientific officer at the Medicines for Malaria Venture (MMV) told SciDev.Net the centre is an opportunity to provide original home-grown drugs for diseases that developed countries hardly pay attention to.

Apart from the MMV, the centre is collaborating with the US National Institutes of Health's National Institute of Allergy and Infectious Diseases, and pharmaceutical companies such as Novartis and GlaxoSmithKline.

The MMV and the TIA will co-fund H-3D to the tune of 20 million rand (around US$3 million) for the next four years. The MMV will also sponsor mentoring programmes for South African researchers.

--

Comments

Post a Comment

Popular posts from this blog

Creating an Africa-wide People's Health Movement

By
Our manifesto As the IPHU participants from the 'Africa Group’ we have agreed that in order to strengthen the movement, we would each need to first start by working locally, strengthening the PHM activities in our respective countries, Ethiopia, Ghana, South Africa, Uganda and Zimbabwe. We commit to support each other in developing and strengthening the PHM in each of our countries as we work towards an Africa-wide People’s Health Movement. The role of PHM is to bring together organisations and individuals already working for the Right to Health under the banner of this shared vision of “Health for all, now!” PHM Africa is an organisation, not a movement. Anyone who endorses the charter and is working in the struggle for the right to health for all can join PHM Africa. The objectives and activities of our campaign are defined and developed by our members. We will strive to further the movement starting on this blog by connecting with others, sharing experiences,...
Post a Comment
Read more

PHA3-Regional Statement- East and Southern Africa

By
REGIONAL STATEMENT – EASTERN & SOUTHERN AFRICA PEOPLE’S HEALTH ASSEMBLY 3 CAPE TOWN 11 JULY 2012 For us the country circle is fundamental. Our starting point would be to identify International People’s Health University (IPHU) alumni in the country; these need to identify an issue and seek local allies who identify with or are working on the issue, begin to develop a campaign and then ask the region for support including connecting them with expertise globally. We have established four working country circles that have lessons we can learn from. We need to develop the embryonic circles in the region through outreach support from the regional level. This can be done by developing a manual based on the lessons from countries (case studies from South Africa, Zimbabwe, Ghana Kenya, as well as experiences from other regions) consisting of principles such as: We need a rallying point or issue that is centred around the right to health (RTH) and this can take di...
Post a Comment
Read more

Seeking Organisational Endorsements: Comments on ‘Draft Technical Paper’ prepared for the World Conference on SDH

By
Seeking Endorsements: Comments on ‘Draft Technical Paper’ prepared for the World Conference on Social Determinants of Health The World Health Organization (WHO) is convening the World Conference on Social Determinants of Health (WCSDH) from 19-21 October 2011 in Rio de Janeiro with the support of the Government of Brazil. The Conference will be organized in accordance with the Resolution 62.14 of the 62nd World Health Assembly and as a follow-up for the work of the WHO Commission on the Social Determinants of Health (CSDH). The WHO has published a ‘Draft Technical Paper’ on the WCSDH and initiated a consultation around it through inviting online submissions. The People’s Health Movement (PHM), in association with several public interest groups and networks, has been coordinating a collective civil society response to the Draft Technical Paper which we strongly believe is a step back from the report of the CSDH ‘Closing the Gap in a Generation: Health equity through action on soci...
Post a Comment
Read more